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Abstract
Background: Adenylation of nicotinate mononucleotide to nicotinate adenine dinucleotide is the
penultimate step in NAD+ synthesis. In Escherichia coli, the enzyme nicotinate mononucleotide
adenylyltransferase is encoded by the nadD gene. We have earlier made an initial characterization
in vivo of two mutant enzymes, NadD72 and NadD74. Strains with either mutation have decreased
intracellular levels of NAD+, especially for one of the alleles, nadD72.
Results: In this study these two mutant proteins have been further characterized together with
ten new mutant variants. Of the, in total, twelve mutations four are in a conserved motif in the C-
terminus and eight are in the active site. We have tested the activity of the enzymes in vitro and
their effect on the growth phenotype in vivo. There is a very good correlation between the two
data sets.
Conclusion: The mutations in the C-terminus did not reveal any function for the conserved motif.
On the other hand, our data has lead us to assign amino acid residues His-19, Arg-46 and Asp-109
to the active site. We have also shown that the nadD gene is essential for growth in E. coli.
Background
Biosynthesis of nicotinamide adenine dinucleotides plays
a central role in the metabolism of all organisms [1,2].
Their primary function is to serve as either donors or
acceptors in biochemical oxidation-reduction reactions.
The nucleotides can also be used as substrates in non-
redox reactions e.g. ADP ribosylation [3], biosynthesis of
cyclic ADP-ribose [4], and as a dehydrating agent for DNA
ligase [5].
There are several metabolic pathways for biosynthesis of
nicotinamide adenine dinucleotide (NAD+) in bacteria
(Figure 1). The de novo pathway consists of five steps; it
starts with the oxidation of aspartate to iminosuccinic
acid, which in turn reacts with dihydroxyacetone phos-
phate to give quinolinic acid (QA). QA is phosphoribo-
sylated and decarboxylated resulting in nicotinic acid
mononucleotide (NAMN). NAMN is adenylated to nico-
tinic acid adenine dinucleotide (NAAD), which in turn is
amidated to complete NAD+ biosynthesis. The genes cod-
ing for the different enzymes in Escherichia coli (E. coli)
have been identified [6,7].
Besides de novo synthesis of NAD+ there are several salvage
pathways where exogenous precursors are converted to
NAMN, which then can be converted to NAD+. This
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means that all the steps leading to NAMN are nonessen-
tial. On the contrary, in the last two reactions, NAMN to
NAAD and NAAD to NAD+, metabolites cannot be sup-
plied from outside the cell. Thus, the enzymes nicotinic
acid mononucleotide adenylyltransferase (NAMNAT) and
NAD synthetase are essential for growth of E. coli (coded
for by the genes nadD and nadE, respectively). However, if
the nadD gene is essential for growth has been questioned.
In a survey with transposon insertions into metabolic
genes, insertions into the nadD gene were found, at the
same time the authors show that the entire gene cannot be
deleted [8]. It should be pointed out that the insertion site
in the nadD gene was not shown.
The E. coli nadD gene has been identified [9] and the crys-
tal structure of the enzyme has been solved [10]. The
enzyme has a molecular weight of 24.5 kD and unlike the
counterparts in Archaea and Eukarya it is suggested to
function as a monomer. The E. coli enzyme shows strong
substrate preference for NAMN rather than for nicotina-
mide mononucleotide (NMN), this is in contrast to the
human and archaeal enzymes [9]. NAMNAT is a member
of the nucleotidyltransferase super family [11], that
includes ATP surfurylase, cytidyltransferase, pantothenate
synthetase, and class I tRNA synthetases. The group is
characterized by a modified dinucleotide-binding fold
(Rossmann-fold) and by the presence of a conserved ATP
binding motif, T/HXGH [11]. The importance of the latter
has been shown [12-14].
We have earlier shown that two mutations in the nadD
gene (nadD72 and nadD74) lead to decreased levels of
NAD+ in the cell [15]. This, in turn, leads to temperature
sensitive growth on synthetic minimal medium for both
mutants. A strain with the nadD72  mutation is most
severely affected and has additional phenotypic changes
Biosynthesis of NAD in bacteria Figure 1
Biosynthesis of NAD in bacteria. Abbreviations: Na, nicotinic acid; Nm, nicotinamide; NMN, nicotinamide mononucleotide; 
NAMN, nicotinic acid mononucleotide; NmR, nicotinamide ribonucleoside; NAAD, nicotinic acid adenine dinucleotide; NAD, 
nicotinamide adenine dinucleotide; NADP, nicotinamide adenine dinucleotide phosphate. Enzymes: nadA codes for quinolinate 
synthase; nadB L-aspartate oxidase; nadC quinolinic acid phosphoribosyltransferase; nadD nicotinic acid mononucleotide adeny-
lyltransferase; nadE NAD synthetase; nadK (nadF) NAD kinase; pncA nicotinamide deamidase; pncB nicotinic acid phosphoribo-
syltransferase; pncC NMN deamidase; nadV* Nm phosphoribosyltransferase (in Haemophilus ducreyi); ligase+? DNA ligase, only 
partially responsible for the activity; nadR bifunctional activity; a)* N-ribosylnicotinamide kinase, b)* NMN adenylyltransferase 
(in H. influenzae); 1) NMN glycohydrolase (gene not yet identified). Some of these steps may occur in the periplasmic space or 
at the inner membrane. Asterisks indicate activities not identified in vivo in E. coli.
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like; complete inability to grow on minimal medium and
temperature sensitive growth on rich medium. Thus, a
link between NAD+ synthesis and ability to grow on differ-
ent substrates at different temperatures was found.
In this paper we have shown that the nadD gene is essen-
tial for growth and we have extended the analysis of the
enzyme by creating ten additional mutants. Seven of them
have mutated residues close to or in the active site, as is
nadD74, and three were created to study the role of the C-
terminus, which is affected by nadD72. All twelve mutant
proteins were analyzed in vitro for activity and in vivo for
their effect on the growth phenotype. The two data sets
correlate very well. We have not been able to find a func-
tion for the C-terminus, while amino acid residues His-19,
Arg-46 and Asp-109 can be assigned to the active site in
accordance with the structure.
Results and discussion
In this work we have studied the function of the E. coli
NAMNAT enzyme. Understanding the enzyme is neces-
sary not only for its central role in metabolism but also for
its possible role as a target for the development of new
antibiotics. In an earlier study we initiated functional
studies of two E. coli NAMNAT mutants [15]. One of the
mutants, nadD72, is a frameshift mutation that changes
the ten last amino acid residues of the protein and adds
seventeen amino acids to the C-terminus [15]. When the
amino acid sequences of bacterial NAMNATs are ana-
lyzed, two conserved residues, Tyr-205 and Ile-206 were
found in the C-terminus. They are both located in the F
helix of the E. coli enzyme, using the nomenclature given
by Zhang et al. [10]. These two residues are changed in the
NadD72 mutant. This lead us to ask whether it is the elon-
gated C-terminus and/or the changed amino acids that
cause the phenotype associated with the mutation. The
other mutation, nadD74, changes Asp-13 to Val. The resi-
due is next to the ATP-binding motif and is highly con-
served [13].
To extend the study of NAMNAT we made three addi-
tional mutant alleles in the C-terminus and seven around
the active site. For the in vivo studies we made a strain with
a chromosomal deletion of the nadD gene, which makes
it possible to study cloned, mutant enzymes in vivo. The
gene on the chromosome was replaced by a cassette
encoding chloramphenicol acetyltransferase [16] and the
strain was called MS10. The gene nadD has been shown
essential in Salmonella typhimurium [17]. However, some
conflicting data on this matter was recently published [8].
The authors have isolated strains with transposon inser-
tions affecting the nadD gene and the strains are viable on
LB. The exact location of the insertion was not shown,
moreover, attempts to delete the nadD  gene from the
chromosome failed. Our results are clear; we could only
delete the nadD gene when the wild type nadD gene was
present on a plasmid in the cell, thus, confirming the
essentiality of the gene.
To study the mutant enzymes in vitro the different alleles
were cloned in a vector under the control of the arabinose
promoter. We first tried to fuse a His6-tag to the N-termi-
nus of the proteins, but the expression level of the pro-
teins was very low and some mutant proteins were
undetectable when analyzed by Western blot (not
shown). We changed to an IgG binding ZZ'-domain as a
tag and the expression level increased considerably. A
thrombin recognition sequence was engineered in the
linker between the ZZ'-tag and the enzyme. However,
removal of the ZZ'-tag from the purified proteins was not
possible. Therefore, all investigated mutants and the wild
type enzyme were assayed with the N-terminal ZZ-tag.
All enzymes were expressed as soluble proteins in strain
TOP10. The final yield was typically 5–20 mg protein/l
culture, similar to an earlier report [9]. The purity was
about 90–95% as estimated by SDS-PAGE after Coomasie
staining. The purified NadD72short protein gave two
bands on the gel. One band had the correct enzyme size,
the other, smaller, is probably a degradation product.
Investigation of the C-terminus
Based on the nadD72 mutation, we designed the mutant
NadD72short with the same change of the ten C-terminal
amino acid residues as nadD72, while the length of the
protein is the same as in the wild type enzyme. We also
constructed two mutants where either Tyr-205 or Ile-206
is changed to alanine.
We have earlier shown that the intracellular level of NAD+
correlates to growth ability on different media and at dif-
ferent temperatures [15]. Thus, we decided to investigate
the effect on growth by the different mutant enzymes.
Plasmids with either of the four mutant alleles,
pZZNadD72, pZZNadD72short, pZZNadDY205A,
pZZNadDI206A, or the wild type gene (pZZNadD) were
transformed into strain MS10 with plasmid pKanNadD
selecting for ApR. Transformants were restreaked on LB
with ampicillin and arabinose to induce expression of the
respective nadD alleles. The transformants were tested for
loss of KmR to ensure plasmid exchange. Thereafter, MS10
with each respective plasmid were streaked on LB plates
with or without arabinose and incubated at 30°C. The
diameter of the colonies was measured. The results are
shown in Table 4. Addition of 0.1 mM arabinose resulted
in growth of all strains. In the absence of arabinose leak-
age expression of the wild type enzyme is enough to sup-
port normal growth while neither of the two mutant
proteins NadD72 or NadD72short are active enough to
do so. This indicates that it is the change in the last 10BMC Biochemistry 2005, 6:16 http://www.biomedcentral.com/1471-2091/6/16
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amino acids and not the elongated C-terminus that
impairs the enzyme. The two mutants with either of the
two conserved residues changed, supported growth like
the wild type enzyme. This shows that to affect enzyme
activity more than one amino acid has to be changed in
the C-terminus.
The same test was performed on minimal medium and it
was found that NadD72 and NadD72short could not sup-
port growth in the presence of 0.1 mM arabinose. How-
ever, at 0.2 mM arabinose enough enzyme was produced
to allow growth (not shown).
A test was also performed on strain MS10 containing plas-
mids carrying the nadD alleles without a ZZ'-tag. We could
not detect any difference in growth behavior whether the
nadD alleles were tagged or not (not shown). This makes
us confident to use the ZZ'-tagged enzymes in vitro.
The enzyme activity of the mutants changed in the C-ter-
minus were measured in vitro. The result can be seen in
Figure 2. The activity of the wild type enzyme was set to 1.
The enzymes NadD72 and NadD72short have almost no
activity in good agreement with the in vivo phenotype. The
other two mutants, NadDY205A and NadDI206A are less
efficient than the wild type enzyme but not enough to
show as a change in the growth phenotype.
The results obtained both in vivo and  in vitro for
NadD72short could indicate that it is not the extension of
NadD72 that causes the deficiency in the protein but
rather the change in the C-terminus. However, this
conclusion is complicated by the finding during purifica-
Relative enzyme activity of different NAMNAT mutants based on in vitro measurements Figure 2
Relative enzyme activity of different NAMNAT mutants based on in vitro measurements. The results are based on at least three 
independent measurements with a standard error of the mean of less than 5%.BMC Biochemistry 2005, 6:16 http://www.biomedcentral.com/1471-2091/6/16
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tion of NadD72short that two bands were visible on the
protein gel, indicating instability of the protein. Thus, the
results obtained for NadD72short are inconclusive.
Another possibility should also be considered. Since the
nadD72 allele causes temperature sensitivity it is possible
that the enzyme activity is lowered at 37°C the tempera-
ture at which the in vitro experiments were performed. To
test this, we grew all mutants at 30°C, 37°C, and 42°C,
respectively. We found that the Ts phenotype not only dis-
appears in the presence of arabinose but that the cells
grow better at the higher temperatures than at 30°C.
Therefore, we do not think that the changes in enzyme
activity are caused by changes in reaction temperature
optimum.
To understand the role of the elongated C-terminus of the
NadD72 mutant, we consider the role of the correspond-
ing region of the human NMNAT. Human NMNAT has a
24 amino acid residues longer C-terminus than E. coli
NAMNAT. It has been suggested that the C-terminus in
human NMNAT plays a role in substrate recognition
[18,19]. The NadD72 enzyme has 17 extra amino acid res-
idues and it is possible that the extension interferes with
substrate binding, which would lead to low enzyme activ-
ity. All we can say with certainty is that the C-terminus is
important for stability of the protein and that the two con-
served amino acid residues do not have a great influence
on activity.
Investigation of the active site
The nadD74 mutation leads to an amino acid change in
position 13 (Asp to Val). The mutated residue is two
amino acids away from the ATP-binding motif, T/HXGH
(position 16 to 19). Crystal structure information was
used to decide which amino acid positions to mutagenize
to learn more about the active site. Residues within 6 Å
distance from the oxygens of the two adjacent phosphate-
groups of the bound NAAD molecule are shown in Figure
3. Based on their close contact and H-bonding abilities
Thr-11, His-19, Asn-40, His-45, Arg-46, Asp-109 and Ser-
110 were selected for mutagenesis. All these residues were
changed to alanine by site-directed mutagenesis. The
recombinant proteins were cloned and analyzed, as were
the C-terminal mutants.
First, growth on LB plates with and without arabinose was
tested. The results are shown in Table 4. All strains grew in
the presence of arabinose as expected. In the absence of
arabinose MS10/pZZNadDN40A and MS10/
pZZNadDS110A behaved basically as MS10 with the wild
type enzyme while the other mutations affected growth
on LB to a varying degree. Second, the enzymatic activity
for the active site mutants was determined in vitro. The
results are summarized in Figure 2. As with the C-terminal
mutants, the correlation between the two experiments is
very good.
Asp-109 and Ser-110 is located in the region connecting
strand d and helix D of NAMNAT [10]. This region is one
of three regions observed to undergo large conforma-
tional changes upon substrate binding. Interestingly,
mutations of these two amino acids affect enzymatic
activity very differently. On the one hand, binding of the
substrate brings Ser-110 closer to the substrate. It is possi-
ble that the side chain of Ser-110 is H-bonded to the 2'-
OH of AMP-ribose. However, mutation of Ser-110 to
alanine resulted in an enzyme with 80% activity as
compared to that of the wild type NadD. Our results indi-
cate that the interaction between Ser-110 and the ribose is
dispensable for substrate coordination. On the other
hand, the change of the highly conserved Asp-109 had a
severe effect on activity. Asp-109 has been proposed to
form an H-bond to the 2'-OH group of AMP [10]. It was
also suggested by the same authors that the carboxylate
oxygen of the residue might be involved in the coordina-
tion of a Mg2+ ion shown to be important for the enzyme
function [10,12]. The location of Asp-109 is ideal to posi-
tion an Mg2+ ion which could act as a Lewis acid stabiliz-
The active site of E. coli nicotinic acid mononucleotide adeny- lyltransferase with bound NAAD (yellow carbons) Figure 3
The active site of E. coli nicotinic acid mononucleotide adeny-
lyltransferase with bound NAAD (yellow carbons). Amino 
acid residues (grey carbons) within 6 Å to NAAD are shown 
(tested in this study). Suggested H-bonds are marked by dot-
ted lines [27]BMC Biochemistry 2005, 6:16 http://www.biomedcentral.com/1471-2091/6/16
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ing the transition state in the transesterification reaction
[10]. However, the functional importance of this con-
served residue has not been investigated earlier. The seri-
ous decrease in enzymatic activity (0.038%) that we
observe supports the above mechanism and serves as an
experimental evidence for the involvement of Asp-109 in
the catalysis.
The Thr-11 main chain nitrogen is H-bonded to the AMP
phosphate in the crystal structure of the NadD-NAAD
complex. This H-bond is expected to be independent of
the side-chain character of the amino acid. However, the
NadDT11A mutant leads to decreased enzyme activity
(2%, Figure 2). The explanation might be that the
hydroxyl group of Thr-11 forms an H-bridge to Asn-40,
which has been shown to interact with 2'-hydroxyl group
of NAMN-ribose [10]. Such an interaction could contrib-
ute to substrate binding and coordination. The change of
Asn-40 to alanine leads to a decreased enzyme activity
(23%, Figure 2). We conclude that the disruption of this
H-bonding network might lead to inefficient substrate
coordination. Therefore, the effect on enzyme activity by
the T11A and/or N40A mutation is possibly indirect.
The mutation D13V (NadD74) was found to lead to
decreased activity of the enzyme. A similar mutation has
been described in CTP:glycerol-3-phosphate cytidyltran-
ferase that is a member of the same enzyme super family
[20]. The residue Asp-11 (which corresponds to Asp-13 in
NAMNAT) was changed to alanine and enzyme activity
was severely reduced. Both valine and alanine are hydro-
phobic amino acids and it is possible that the change dis-
turbs ATP binding; resulting in lower enzyme activity. It is
not clear whether the role of Asp in this position is catalyt-
ical or structural.
The role of the second histidine (His-19) in the conserved
T/HXGH motif has been tested in several studies and been
shown to play a role in ATP-binding and stabilization, but
the role for the two histidine residues can vary between
enzymes [14,21]. Our results confirm the previous
observations. The mutation H19A leads to a decrease in
enzyme activity to 0.62% of the wild type activity.
Amino acid residues His-45 and Arg-46 are part of a flexi-
ble loop in the NadD enzyme, which moves upon sub-
strate binding. The two residues are conserved within
NMNAT from Bacteria and Eukarya but not in the known
archaeal enzymes. His-45 is involved in a hydrophobic
stacking interaction with the pyridine ring in NAMN and
is also likely to form an H-bond with the NAMN phos-
phate group. Histidines are often involved in acid base
catalysis, and prone to activate nucleophiles by abstract-
ing a proton. The H45A change led to an enzyme with 4%
residual activity, while the R46A mutant was the most
affected of all tested active site mutants. If the role of Arg-
46 in the substrate binding loop was simply to protect the
bound substrates, higher rates of ATP hydrolysis is
expected in the case of the R46A mutant. Since the R46A
mutant did not produce AMP as by-product in the in vitro
experiment, the role of this arginine side chain must be
more than simply protecting the bound substrates from
water molecules. The guanidinium group of Arg-46 lies in
an ideal position to serve as a positively charged moiety
that stabilizes the juxtaposed and negatively charged
phosphates of the substrate molecules, as well as of the
product NAAD. The archaeal orthologues lack the precise
sequence homology in the sequence aligned to the H45-
R46, but they have a conserved arginine (Arg-8 in Meth-
anococcus jannaschii) that occupies the same position with
its side chain in the ATP-enzyme complex as that of Arg-
46 in the E. coli NadD enzyme [10,12]. On the other hand
another hypothesis should be considered as well. Muta-
tional studies on NMNAT from Methanobacterium thermo-
autotrophicum  indicate that the archaeal enzyme is
involved in the reaction merely by placing the substrates
in an ideal position [14]. Combining the facts above, we
conclude that Arg-46 in E. coli NadD plays an important
role in stabilizing the two adjacent, negatively charged,
phosphate moieties during catalysis. A similar role might
Table 1: Strains used in this study
Strain Genotype Source
MRA530 rph nadA::Tn10 gal490(?) λ cI857 ∆(cro-biol)(?) MRA strain collection
RI8 ara ∆(gpt-lac)5 nadD72 zbe280::Tn10 [15]
RI10 ara ∆(gpt-lac)5 zbe280::Tn10 [15]
RI12 ara ∆(gpt-lac)5 nadD74 zbe280::Tn10 [15]
MS10 as RI10 but nadD::Cm This study
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 deoR recA1 araD139 ∆(ara-leu)7697 galU galK rpsL 
endA1 nupG
Invitrogen, Carslbad, CA
DH5α F-,φ80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, endA, hsdR17(rk-, rk+), supE44, gyrA96, relA1 [25]BMC Biochemistry 2005, 6:16 http://www.biomedcentral.com/1471-2091/6/16
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be attributed to Arg-8 in the archaeal counterparts but this
has to be tested.
Conclusion
We have investigated mutants in both the C-terminus and
the active site of E. coli NAMNAT in two assay systems;
effect on growth on plates and in vitro activity of the
enzyme. Correlation between the two data sets is very
good and shows that there is a distinct threshold where
there is enough activity to support growth.
The data obtained are not enough to assess the function of
the C-terminus; more work is needed. As for to the active
site we have found that amino acid residues His-19, His-
45, Arg-46 and Asp-109 are likely needed for catalysis,
while Asp-13 probably affects substrate binding indi-
rectly. We have also shown the essentiality of the nadD
gene in E. coli.
Methods
Bacterial strains and media
Bacterial strains and plasmids used in this work are listed
in Tables 1 and 2, respectively. Luria-Bertani (LB) medium
and M9 minimal medium were prepared according to
Miller [22]. The concentrations of antibiotics were, 15 µg/
ml chloramphenicol, 200 µg/ml ampicillin (Ap) and 50
µg/ml kanamycin (Km).
Standard recombinant DNA techniques were used for
cloning of DNA [23]. E. coli strain DH5α was used as a
recipient for cloned DNA. Restriction and modification
enzymes were purchased from New England Biolabs,
Amersham Pharmacia Biotech or Life Technologies. DNA
fragments were separated by agarose gel electrophoresis,
excised and purified using the Qiaex II Gel Extraction Kit
(Qiagen). Oligonucleotides were purchased from MWG
Biotech. Plasmid DNA was purified with QiaPrep Kit
(Qiagen). MWG Biotech did DNA sequencing. ATP and
NAMN were purchased from Sigma.
Construction of a nadD strain and a plasmid-exchange 
system
Primers used in this study are listed in Table 3. Before
deleting the nadD gene from the chromosome we had to
clone the wild type gene. The nadD wild type gene was
amplified from RI10 with primers PARA1 and PARA2 and
cloned into plasmid pBAD-Kan. The plasmid was named
pKanNadD. The plasmid pBAD-Kan is identical to pBAD-
myc-hisA but with a kanamycin resistance gene from
pUC4K inserted into the ampicillin resistance gene. Thus,
pBAD-Kan confers kanamycin resistance and not ampicil-
lin resistance.
To delete the nadD gene from the chromosome we used
linear DNA transformation and the λ red recombination
system [16]. Primers used for amplification of the chlo-
ramphenicol acetyltransferase gene with homologies to
the ends of nadD were PNadko1b and PNadko2b. The
amplified linear DNA was electroporated into strain
MRA530/pKanNadD and chloramphenicol resistant
(CmR) colonies were selected. Recombinants were
checked for proper exchange by PCR amplification and
sequence verification. A P1 phage lysate made on one
such recombinant was transduced to RI10/pKanNadD
selecting for CmR. Transductants were verified by PCR,
one clone was kept and named MS10. The plasmid could
now be exchanged for a pBADmyc-hisA (ApR) plasmid
carrying different nadD alleles. The exchange relies on the
incompatibility of pKanNadD and pBADmyc-hisA.
Construction of expression vectors with different nadD 
alleles
The nadD72 allele from RI8 was amplified with primers
PARA1 and PD1, the nadD74  allele from RI12 with
Table 2: Plasmids used in this study.
Plasmid name description
pEZZ18 Pharmacia Biotech/GE Healthcare
pUC4K Pharmacia Biotech/GE Healthcare
pBADmyc-hisA Invitrogen (ApR)
pBAD-Kan As pBADmyc-hisA but KmR
pKanNadD wild type nadD in pBAD-Kan
pNadD wild type nadD
pNadD72 nadD72(D13V)
pNadD74 nadD74
pNadD72short nadD72 without the extension
pNadDT11A nadD with mutation T11A
pNadDH19A nadD with mutation H19A
pNadDN40A nadD with mutation N40A
pNadDH45A nadD with mutation H45A
pNadDR46A nadD with mutation R46A
pNadDD109A nadD with mutation D109A
pNadDS110A nadD with mutation S110A
pNadDY205A nadD with mutation Y205A
pNadDI206A nadD with mutation I206A
pZZNadD pNadD + ZZ'-tag N-terminal fusion
pZZNadD72 pNadD72 + ZZ'-tag N-terminal fusion
pZZNadD74 pNadD74 + ZZ'-tag N-terminal fusion
pZZNadD72short pNadD72short + ZZ'-tag N-terminal fusion
pZZNadDT11A pNadDT11A + ZZ'-tag N-terminal fusion
pZZNadDH19A pNadDH19A + ZZ'-tag N-terminal fusion
pZZNadDN40A pNadDN40A + ZZ'-tag N-terminal fusion
pZZNadDH45A pNadDH45A + ZZ'-tag N-terminal fusion
pZZNadDR46A pNadDR46A + ZZ'-tag N-terminal fusion
pZZNadDD109A pNadDD109A + ZZ'-tag N-terminal fusion
pZZNadDS110A pNadDS110A + ZZ'-tag N-terminal fusion
pZZNadDY205A pNadDY205A+ ZZ'-tag N-terminal fusion
pZZNadDI206A pNadDI206A + ZZ'-tag N-terminal fusion
All plasmids below line three were made in this study. All plasmids 
below line five are derivatives of pBADMyc-hisA.BMC Biochemistry 2005, 6:16 http://www.biomedcentral.com/1471-2091/6/16
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primers PARA1 and PARA2 and the nadD72short  allele
from RI8 with primers PARA1 and PD72short. The
nadD72short allele has the same change at the C-terminus
as the nadD72 allele but with the same length as the wild
type allele. Site-directed mutagenesis was performed on
the cloned wild type allele using QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Oligo-
nucleotides used are listed in Table 3.
All allele variants were cloned in the expression vector
pBADmyc-hisA under the control of an arabinose-pro-
moter using the NcoI and KpnI sites. The resulting plas-
mids are listed in Table 2. Thereafter all alleles were fused
at their 5'-end to a fragment containing an IgG binding
ZZ'-domain from the pEZZ18 vector. This set of plasmids
has the same origin of replication as the pKanNadD but
they confer ampicillin resistance (Table 2). This makes it
possible to exchange plasmid pKanNadD in the MS10
strain for plasmids carrying mutant nadD alleles.
Protein expression and purification
E. coli TOP10 cells containing plasmids with respective
nadD allele (pZZNadDXX) were grown in LB medium at
30°C. When the cultures reached OD550 0.5, arabinose
was added to a final concentration of 0.4 mM. After ~4 h
growth, the cultures were quickly chilled on ice and har-
vested by centrifugation. Pellets were stored at -20°C. The
frozen pellets were thawed, resuspended in 10 × TST (0.5
M Tris pH 7.4, 1.5 M NaCl, 5% w/v Tween 20), lysozyme
(1 mg/ml), DNase I (20 µg/ml) and RNase A (20 µg/ml).
After incubation at 37°C and several freezing (in liquid
nitrogen) and thawing cycles, samples were sonicated and
the lysate was cleared by centrifugation. Proteins were
purified as described [24]. The solvent was changed to
reaction buffer [9] on a NAP5 desalting column (Amer-
sham Biosciences, Uppsala, Sweden). Purification effi-
ciency was monitored by SDS-polyacrylamide gel
elecrophoresis (PAGE) and stained by Coomasie blue.
The protein concentration was determined by UV spectro-
photometry at 280 nm [26].
Assay of enzymatic activity
In vitro enzymatic activity of NAMNAT was determined as
described [9]. The substrate concentrations were 2 mM
ATP and 1 mM NAMN and the reaction was carried out at
37°C. The enzyme concentration was 1 µg/100 µl. Reac-
tions were terminated by immersing the tubes in boiling
water for 5 minutes. They were thereafter cooled on ice
Table 3: Oligonucleotides used in this study.
Primer sequence
PNadko1b 5'- ATAAACCCCTGGCGGACGTATTTATCGACGGTTGATCATATGAATATCCTCCTTAG-3'
PNadko2b 5'- TGGTCGCCGAGATGTTAAACCACGGCGTTTCAGCCAGTGTAGGCTGGAGCTGCTTC-3'
PARA1 5'-AACCATGGAATCTTTACAGGCTCTGTTTGGC-3'
PARA2 5'-TTAAGGTACCGTAACGACAGGTATCAGCGAT-3'
PD1 5'-TTAAGGTACCTCACCATGACGAATTAACCAC-3'
PD72short 5'-TTAAGGTACCTCAAGCGATACAAGCCTTGTT-3'
T11A* 5'-ACAGGCTCTGTTTGGCGGCGCCTTTGATCCGGT-3'
H19A* 5'-GATCCGGTGCACTATGGTGCTCTAAAACCCGTGGAA-3'
N40A* 5'-CGGGTCACAATCATCCCTGCTAATGTTCCTCCGCAT-3'
H45A* 5'-CTAATAATGTTCCTCCGGCTCGTCCCCAAGCCGGAAGC-3'
R46A* 5'-CTAATAATGTTCCTCCGCATGCTCCCCAGCCGGAAGC-3'
D109A* 5'-TTTATTATTGGTCAGGCTTCACTGCTGACCTTTCCG-3'
S110A* 5'-ATTATTGGTCAGGATGCACTGCTGACCTTTCCGACC-3'
Y205A* 5'-GGAACCGGTACTGACTGCCATTAACCAACAAGGCTTG-3'
I206A* 5'-GGAACCGGTACTGACTTACGCTAACCAACAAGGCTTG-3'
* oligonucleotides used for site directed mutagenesis. The mutated codons are shown in bold, the changed nucleotides are underlined.
Table 4: 
MS10 + different plasmids 24 hours 48 hours
pZZNadD 1.1† 2.5
pZZNadD72 n.g.* n.g.
pZZNadD74 n.g. n.g.
pZZNadDY205A 1 2.2
pZZNadDI206A 1 2.3
pZZNadDT11A 0.2–0.5 1–1.5
pZZNadD74 0.6 1.2
pZZNadDH19A 0.2 0.6
pZZNadDN40A 1 2.1
pZZNadDH45A 0.8 1.4
pZZNadDR46A 0.2 1
pZZNadDD109A 0.1 0.3
pZZNadDS110A 1 2.2
†Colony size (diameter in mm); grown on LB without arabinose at 
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and filtered through Nanosep 10 K microcentrifugal
devices to take away the enzyme (Pall, Ann Arbor, MI). 20
µl aliquots were analyzed by high-pressure liquid chroma-
tography on a Gilson LC system by using Supelcosil LC-
18-T 15 cm by 4.6 mm column (Supelco, Bellefonte, PA).
The product formation was monitored at 254 nm as a
function of time and the initial reaction rate was calcu-
lated from the slope of the curve. The rate for the wild type
enzyme that was set to 1, rates for the mutant enzymes
were correlated to this.
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